West Pharmaceutical Services, Inc.

WST

Market Cap$26.95B

Close$

Compare West Pharmaceutical Services

	P/E Ratio	Dividends	Return on Equity	Price-to-Sales	Debt-to-Equity
West Pharmaceutical Services, Inc.	45.4	0.21%	21%	9	0.1
Market Avg	58.9	1.29%	29%	-	1
Healthcare Avg	66.3	1.31%	15%	-	0.9

$536.00

Target Price by Analysts

48.7% upsideWest Pharmaceutical Services Target Price Details

$156.57

Current Fair Value

56.6% downside

Overvalued by 56.6% based on the discounted cash flow analysis.

Share Statistics

Market cap	$26.95 Billion
Enterprise Value	$26.31 Billion
Dividend Yield	$0.7895 (0.21%)
Earnings per Share	$7.88
Beta	0.0
Outstanding Shares	73,205,367
Avg 30 Day Volume	390,447

Return

Return on Equity	-
Return on Assets	-
Return on Invested Capital	-

Valuation & Multiples

P/E Ratio	45.42
PEG	137.6
Price to Sales	9.01
Price to Book Ratio	9.24
Enterprise Value to Revenue	8.92
Enterprise Value to EBIT	36.28
Enterprise Value to Net Income	44
Total Debt to Enterprise	0.01
Debt to Equity	0.07

Revenue Sources

No data

ESG Score

No data

About West Pharmaceutical Services, Inc.

CEO: Eric Green